Does LAH May Improve the Pregnancy Outcomes?

Status Recruiting

Clinical Trial Summary

A defect in the hatching stage is considered an important cause of implantation failure. Therefore, assisted hatching (AH), which involves artificial disruption of the zona pellucida, has been proposed as a method for improving the capacity of the embryo to implant. But the advantage of using laser to facilitate the hatching process of embryos in ART practice is debatable, and an optimum strategy for performing LAH remains elusive. Therefore, the aim of this study was to evaluate the effects of laser-assisted hatching(LAH) on clinical outcomes. Patients were randomly divided into control and LAH groups. The zona pellucida was thinned or drilled with a diode laser. Relevant parameters are recorded to evaluate the validity of LAH in ART.

Clinical Trial Description

Hatching is a very important process for successful implantation involving the breaking of the embryo out of the zona pellucida at the blastocyst stage. Inadequate hatching of the blastocyst might lead to implantation failure in ART. Currently, a variety of AH techniques have been used including zona thinning and the opening or complete removal of the zona by laser. But the advantage of using laser to facilitate the hatching process of embryos in ART practice is debatable, and an optimum strategy for performing LAH remains elusive. Therefore, the investigator aim to discuss the effectiveness of LAH in ART.

In this study, patients were randomly divided into control and LAH groups. A quarter of zona pellucida of the cleavage-stage embryo was thinned to 6.6 μm. All operation was performed in the empty region without contact to the blastomere in order to minimize the blastomere damage. The ZP of blastocyst was drilled with laser, the ZP opening 20% of its initial length. The operation was performed in the opposite region of ICM in order to minimize the damage. In the control group, embryos were transplanted without LAH. The rate of clinical pregnancy, live-birth, miscarriage, multiple gestation were evaluated. This research intends to discuss whether LAH can improve the clinical outcomes in ART, and further choice the appropriate LAH action site. ;

Study Design

Related Conditions & MeSH terms

Pregnancy Outcomes

Clinical Trial Details

NCT number	NCT03810157
Study type	Interventional
Source	Tang-Du Hospital
Contact	Ming Wang
Phone	8613259809290
Email	wangmingbio@snnu.edu.cn
Status	Recruiting
Phase	N/A
Start date	December 26, 2018
Completion date	November 1, 2019

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT05827731` - Cervical Double Balloon Combined With Oxytocin	N/A
Completed	`NCT01222247` - Antenatal Late Preterm Steroids (ALPS): A Randomized Placebo-Controlled Trial	Phase 3
Active, not recruiting	`NCT04595760` - Factors Influencing Fertility or Pregnancy Health
Completed	`NCT05143710` - The Clinical and Prognostic Features of PRES
Completed	`NCT03048669` - Long Term Outcomes of Therapy in Women Initiated on Lifelong ART Because of Pregnancy in DR Congo	N/A
Completed	`NCT02865759` - Mindfetalness to Improve Pregnancy Outcome	N/A
Recruiting	`NCT03381495` - The Association Between Epidural Labor Analgesia and Pregnancy Outcomes	N/A
Recruiting	`NCT05403632` - Mediterranean Diet on Pregnancy and Foetus Development
Recruiting	`NCT03269916` - Fertility and Ovarian Reserve Function in the Patient With Inflammatory Bowel Disease	N/A
Recruiting	`NCT05154331` - Antenatal and Postnatal Care Research Collective - Household Survey (ARCH)
Not yet recruiting	`NCT05503849` - Born In Guangzhou Intervention Study	N/A
Active, not recruiting	`NCT03814395` - Peking University Birth Cohort in Tongzhou
Recruiting	`NCT04997460` - Diabetes Type One in Pregnancy and Continuos Glucose Monitoring
Recruiting	`NCT06254716` - A Study on the Prognosis of Two Different Surgery Methods in Patients With Rectal Endometriosis
Not yet recruiting	`NCT06234332` - Peking University Birth Cohort in Weifang (PKUBC-WF)
Recruiting	`NCT02526901` - The Born in Guangzhou Cohort Study (BIGCS)
Completed	`NCT00197548` - A Trial of Micronutrients and Adverse Pregnancy Outcomes	Phase 3

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.